3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Conditions
Breast Neoplasms
60
Neoplasms
58
Lung Neoplasms
32
Prostatic Neoplasms
24
Colorectal Neoplasms
24
Carcinoma, Non-Small-Cell Lung
21
Neoplastic Cells, Circulating
20
Head and Neck Neoplasms
19
Pancreatic Neoplasms
17
Melanoma
14
Ovarian Neoplasms
13
Carcinoma, Hepatocellular
12
Esophageal Neoplasms
10
Colonic Neoplasms
10
Uterine Cervical Neoplasms
9
Liver Neoplasms
9
Glioma
9
Squamous Cell Carcinoma of Head and Neck
8
Multiple Myeloma
8
Leukemia, Myeloid, Acute
8
Sarcoma
7
Neoplasm Metastasis
7
Endometrial Neoplasms
7
Stomach Neoplasms
6
Neoplasm, Residual
6
Myeloproliferative Disorders
6
Leukemia
6
Kidney Neoplasms
6
Gastrointestinal Neoplasms
6
Carcinoma, Renal Cell
6
Interventions
Data Collection
3
Blood Specimen Collection
2
human papillomavirus vaccine, L1 type 16, 18
1
apremilast
1
Watchful Waiting
1
Telemedicine
1
Surveys and Questionnaires
1
Standard of Care
1
Practice Guidelines as Topic
1
Phlebotomy
1
Mycophenolic Acid
1
Methods
1
Mastectomy, Segmental
1
Mammaplasty
1
Interviews as Topic
1
Immunotherapy
1
Immune Checkpoint Inhibitors
1
Educational Status
1
Early Intervention, Educational
1
Dietary Fiber
1
CT-P13
1
Azathioprine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Autoimmune Diseases
×
Blood Specimen Collection
×
Clear all
NCT00704626
2026-05-18
SAA
University of California, Davis
Enrolling by invitation
120 enrolled
NCT06002945
2024-12-10
EXPLORE-MG2
Yale University
Active not recruiting
400 enrolled